Pharma & Healthcare
Global Swine Vaccines Market Research Report 2026
- Mar 17, 26
- ID: 738886
- Pages: 128
- Figures: 131
- Views: 15
This report delivers a comprehensive overview of the global Swine Vaccines market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Swine Vaccines. The Swine Vaccines market size, estimates, and forecasts are provided in terms of sales volume (M Doses) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Swine Vaccines market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Swine Vaccines manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Merck
Boehringer Ingelheim
Jinyu Bio-Technology
CAHIC
Tecon
Zoetis
Ceva
Hile Bio
Chopper Biology
WINSUN
Hipra
Ringpu Biology
ChengDu Tecbond
DHN
CAVAC
Virbac
HVRI
Bioveta
Cavet Bio
BIGVET Biotech
Segment by Type
CSF Vaccines
FMD Vaccines
Porcine Circovirus Vaccines
PRRS Vaccines
Others
by Application
Government Tender
Market Sales
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Swine Vaccines manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Swine Vaccines sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The report segments the global Swine Vaccines market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Swine Vaccines manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Merck
Boehringer Ingelheim
Jinyu Bio-Technology
CAHIC
Tecon
Zoetis
Ceva
Hile Bio
Chopper Biology
WINSUN
Hipra
Ringpu Biology
ChengDu Tecbond
DHN
CAVAC
Virbac
HVRI
Bioveta
Cavet Bio
BIGVET Biotech
Segment by Type
CSF Vaccines
FMD Vaccines
Porcine Circovirus Vaccines
PRRS Vaccines
Others
by Application
Government Tender
Market Sales
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Swine Vaccines manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Swine Vaccines sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 Swine Vaccines Market Overview
1.1 Product Definition
1.2 Swine Vaccines by Type
1.2.1 Global Swine Vaccines Market Value by Type: 2025 vs 2032
1.2.2 CSF Vaccines
1.2.3 FMD Vaccines
1.2.4 Porcine Circovirus Vaccines
1.2.5 PRRS Vaccines
1.2.6 Others
1.3 Swine Vaccines by Application
1.3.1 Global Swine Vaccines Market Value by Application: 2025 vs 2032
1.3.2 Government Tender
1.3.3 Market Sales
1.4 Global Swine Vaccines Market Size Estimates and Forecasts
1.4.1 Global Swine Vaccines Revenue 2021–2032
1.4.2 Global Swine Vaccines Sales 2021–2032
1.4.3 Global Swine Vaccines Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Swine Vaccines Market Competition by Manufacturers
2.1 Global Swine Vaccines Sales Market Share by Manufacturers (2021–2026)
2.2 Global Swine Vaccines Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Swine Vaccines Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Swine Vaccines, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Swine Vaccines, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Swine Vaccines, Product Types and Applications
2.7 Global Key Manufacturers of Swine Vaccines, Date of Entry into the Industry
2.8 Global Swine Vaccines Market Competitive Situation and Trends
2.8.1 Global Swine Vaccines Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Swine Vaccines Players Market Share by Revenue
2.8.3 Global Swine Vaccines Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Swine Vaccines Market Scenario by Region
3.1 Global Swine Vaccines Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Swine Vaccines Sales by Region: 2021–2032
3.2.1 Global Swine Vaccines Sales by Region: 2021–2026
3.2.2 Global Swine Vaccines Sales by Region: 2027–2032
3.3 Global Swine Vaccines Revenue by Region: 2021–2032
3.3.1 Global Swine Vaccines Revenue by Region: 2021–2026
3.3.2 Global Swine Vaccines Revenue by Region: 2027–2032
3.4 North America Swine Vaccines Market Facts & Figures by Country
3.4.1 North America Swine Vaccines Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Swine Vaccines Sales by Country (2021–2032)
3.4.3 North America Swine Vaccines Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Swine Vaccines Market Facts & Figures by Country
3.5.1 Europe Swine Vaccines Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Swine Vaccines Sales by Country (2021–2032)
3.5.3 Europe Swine Vaccines Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Swine Vaccines Market Facts & Figures by Region
3.6.1 Asia Pacific Swine Vaccines Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Swine Vaccines Sales by Region (2021–2032)
3.6.3 Asia Pacific Swine Vaccines Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Swine Vaccines Market Facts & Figures by Country
3.7.1 Latin America Swine Vaccines Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Swine Vaccines Sales by Country (2021–2032)
3.7.3 Latin America Swine Vaccines Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Swine Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Swine Vaccines Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Swine Vaccines Sales by Country (2021–2032)
3.8.3 Middle East and Africa Swine Vaccines Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Swine Vaccines Sales by Type (2021–2032)
4.1.1 Global Swine Vaccines Sales by Type (2021–2026)
4.1.2 Global Swine Vaccines Sales by Type (2027–2032)
4.1.3 Global Swine Vaccines Sales Market Share by Type (2021–2032)
4.2 Global Swine Vaccines Revenue by Type (2021–2032)
4.2.1 Global Swine Vaccines Revenue by Type (2021–2026)
4.2.2 Global Swine Vaccines Revenue by Type (2027–2032)
4.2.3 Global Swine Vaccines Revenue Market Share by Type (2021–2032)
4.3 Global Swine Vaccines Price by Type (2021–2032)
5 Segment by Application
5.1 Global Swine Vaccines Sales by Application (2021–2032)
5.1.1 Global Swine Vaccines Sales by Application (2021–2026)
5.1.2 Global Swine Vaccines Sales by Application (2027–2032)
5.1.3 Global Swine Vaccines Sales Market Share by Application (2021–2032)
5.2 Global Swine Vaccines Revenue by Application (2021–2032)
5.2.1 Global Swine Vaccines Revenue by Application (2021–2026)
5.2.2 Global Swine Vaccines Revenue by Application (2027–2032)
5.2.3 Global Swine Vaccines Revenue Market Share by Application (2021–2032)
5.3 Global Swine Vaccines Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Swine Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Merck Swine Vaccines Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Boehringer Ingelheim
6.2.1 Boehringer Ingelheim Company Information
6.2.2 Boehringer Ingelheim Description and Business Overview
6.2.3 Boehringer Ingelheim Swine Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Boehringer Ingelheim Swine Vaccines Product Portfolio
6.2.5 Boehringer Ingelheim Recent Developments/Updates
6.3 Jinyu Bio-Technology
6.3.1 Jinyu Bio-Technology Company Information
6.3.2 Jinyu Bio-Technology Description and Business Overview
6.3.3 Jinyu Bio-Technology Swine Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Jinyu Bio-Technology Swine Vaccines Product Portfolio
6.3.5 Jinyu Bio-Technology Recent Developments/Updates
6.4 CAHIC
6.4.1 CAHIC Company Information
6.4.2 CAHIC Description and Business Overview
6.4.3 CAHIC Swine Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 CAHIC Swine Vaccines Product Portfolio
6.4.5 CAHIC Recent Developments/Updates
6.5 Tecon
6.5.1 Tecon Company Information
6.5.2 Tecon Description and Business Overview
6.5.3 Tecon Swine Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Tecon Swine Vaccines Product Portfolio
6.5.5 Tecon Recent Developments/Updates
6.6 Zoetis
6.6.1 Zoetis Company Information
6.6.2 Zoetis Description and Business Overview
6.6.3 Zoetis Swine Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Zoetis Swine Vaccines Product Portfolio
6.6.5 Zoetis Recent Developments/Updates
6.7 Ceva
6.7.1 Ceva Company Information
6.7.2 Ceva Description and Business Overview
6.7.3 Ceva Swine Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Ceva Swine Vaccines Product Portfolio
6.7.5 Ceva Recent Developments/Updates
6.8 Hile Bio
6.8.1 Hile Bio Company Information
6.8.2 Hile Bio Description and Business Overview
6.8.3 Hile Bio Swine Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Hile Bio Swine Vaccines Product Portfolio
6.8.5 Hile Bio Recent Developments/Updates
6.9 Chopper Biology
6.9.1 Chopper Biology Company Information
6.9.2 Chopper Biology Description and Business Overview
6.9.3 Chopper Biology Swine Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Chopper Biology Swine Vaccines Product Portfolio
6.9.5 Chopper Biology Recent Developments/Updates
6.10 WINSUN
6.10.1 WINSUN Company Information
6.10.2 WINSUN Description and Business Overview
6.10.3 WINSUN Swine Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 WINSUN Swine Vaccines Product Portfolio
6.10.5 WINSUN Recent Developments/Updates
6.11 Hipra
6.11.1 Hipra Company Information
6.11.2 Hipra Description and Business Overview
6.11.3 Hipra Swine Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Hipra Swine Vaccines Product Portfolio
6.11.5 Hipra Recent Developments/Updates
6.12 Ringpu Biology
6.12.1 Ringpu Biology Company Information
6.12.2 Ringpu Biology Description and Business Overview
6.12.3 Ringpu Biology Swine Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Ringpu Biology Swine Vaccines Product Portfolio
6.12.5 Ringpu Biology Recent Developments/Updates
6.13 ChengDu Tecbond
6.13.1 ChengDu Tecbond Company Information
6.13.2 ChengDu Tecbond Description and Business Overview
6.13.3 ChengDu Tecbond Swine Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 ChengDu Tecbond Swine Vaccines Product Portfolio
6.13.5 ChengDu Tecbond Recent Developments/Updates
6.14 DHN
6.14.1 DHN Company Information
6.14.2 DHN Description and Business Overview
6.14.3 DHN Swine Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 DHN Swine Vaccines Product Portfolio
6.14.5 DHN Recent Developments/Updates
6.15 CAVAC
6.15.1 CAVAC Company Information
6.15.2 CAVAC Description and Business Overview
6.15.3 CAVAC Swine Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 CAVAC Swine Vaccines Product Portfolio
6.15.5 CAVAC Recent Developments/Updates
6.16 Virbac
6.16.1 Virbac Company Information
6.16.2 Virbac Description and Business Overview
6.16.3 Virbac Swine Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Virbac Swine Vaccines Product Portfolio
6.16.5 Virbac Recent Developments/Updates
6.17 HVRI
6.17.1 HVRI Company Information
6.17.2 HVRI Description and Business Overview
6.17.3 HVRI Swine Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 HVRI Swine Vaccines Product Portfolio
6.17.5 HVRI Recent Developments/Updates
6.18 Bioveta
6.18.1 Bioveta Company Information
6.18.2 Bioveta Description and Business Overview
6.18.3 Bioveta Swine Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Bioveta Swine Vaccines Product Portfolio
6.18.5 Bioveta Recent Developments/Updates
6.19 Cavet Bio
6.19.1 Cavet Bio Company Information
6.19.2 Cavet Bio Description and Business Overview
6.19.3 Cavet Bio Swine Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 Cavet Bio Swine Vaccines Product Portfolio
6.19.5 Cavet Bio Recent Developments/Updates
6.20 BIGVET Biotech
6.20.1 BIGVET Biotech Company Information
6.20.2 BIGVET Biotech Description and Business Overview
6.20.3 BIGVET Biotech Swine Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.20.4 BIGVET Biotech Swine Vaccines Product Portfolio
6.20.5 BIGVET Biotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Swine Vaccines Industry Chain Analysis
7.2 Swine Vaccines Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Swine Vaccines Production Mode & Process Analysis
7.4 Swine Vaccines Sales and Marketing
7.4.1 Swine Vaccines Sales Channels
7.4.2 Swine Vaccines Distributors
7.5 Swine Vaccines Customer Analysis
8 Swine Vaccines Market Dynamics
8.1 Swine Vaccines Industry Trends
8.2 Swine Vaccines Market Drivers
8.3 Swine Vaccines Market Challenges
8.4 Swine Vaccines Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Swine Vaccines by Type
1.2.1 Global Swine Vaccines Market Value by Type: 2025 vs 2032
1.2.2 CSF Vaccines
1.2.3 FMD Vaccines
1.2.4 Porcine Circovirus Vaccines
1.2.5 PRRS Vaccines
1.2.6 Others
1.3 Swine Vaccines by Application
1.3.1 Global Swine Vaccines Market Value by Application: 2025 vs 2032
1.3.2 Government Tender
1.3.3 Market Sales
1.4 Global Swine Vaccines Market Size Estimates and Forecasts
1.4.1 Global Swine Vaccines Revenue 2021–2032
1.4.2 Global Swine Vaccines Sales 2021–2032
1.4.3 Global Swine Vaccines Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Swine Vaccines Market Competition by Manufacturers
2.1 Global Swine Vaccines Sales Market Share by Manufacturers (2021–2026)
2.2 Global Swine Vaccines Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Swine Vaccines Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Swine Vaccines, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Swine Vaccines, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Swine Vaccines, Product Types and Applications
2.7 Global Key Manufacturers of Swine Vaccines, Date of Entry into the Industry
2.8 Global Swine Vaccines Market Competitive Situation and Trends
2.8.1 Global Swine Vaccines Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Swine Vaccines Players Market Share by Revenue
2.8.3 Global Swine Vaccines Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Swine Vaccines Market Scenario by Region
3.1 Global Swine Vaccines Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Swine Vaccines Sales by Region: 2021–2032
3.2.1 Global Swine Vaccines Sales by Region: 2021–2026
3.2.2 Global Swine Vaccines Sales by Region: 2027–2032
3.3 Global Swine Vaccines Revenue by Region: 2021–2032
3.3.1 Global Swine Vaccines Revenue by Region: 2021–2026
3.3.2 Global Swine Vaccines Revenue by Region: 2027–2032
3.4 North America Swine Vaccines Market Facts & Figures by Country
3.4.1 North America Swine Vaccines Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Swine Vaccines Sales by Country (2021–2032)
3.4.3 North America Swine Vaccines Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Swine Vaccines Market Facts & Figures by Country
3.5.1 Europe Swine Vaccines Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Swine Vaccines Sales by Country (2021–2032)
3.5.3 Europe Swine Vaccines Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Swine Vaccines Market Facts & Figures by Region
3.6.1 Asia Pacific Swine Vaccines Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Swine Vaccines Sales by Region (2021–2032)
3.6.3 Asia Pacific Swine Vaccines Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Swine Vaccines Market Facts & Figures by Country
3.7.1 Latin America Swine Vaccines Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Swine Vaccines Sales by Country (2021–2032)
3.7.3 Latin America Swine Vaccines Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Swine Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Swine Vaccines Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Swine Vaccines Sales by Country (2021–2032)
3.8.3 Middle East and Africa Swine Vaccines Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Swine Vaccines Sales by Type (2021–2032)
4.1.1 Global Swine Vaccines Sales by Type (2021–2026)
4.1.2 Global Swine Vaccines Sales by Type (2027–2032)
4.1.3 Global Swine Vaccines Sales Market Share by Type (2021–2032)
4.2 Global Swine Vaccines Revenue by Type (2021–2032)
4.2.1 Global Swine Vaccines Revenue by Type (2021–2026)
4.2.2 Global Swine Vaccines Revenue by Type (2027–2032)
4.2.3 Global Swine Vaccines Revenue Market Share by Type (2021–2032)
4.3 Global Swine Vaccines Price by Type (2021–2032)
5 Segment by Application
5.1 Global Swine Vaccines Sales by Application (2021–2032)
5.1.1 Global Swine Vaccines Sales by Application (2021–2026)
5.1.2 Global Swine Vaccines Sales by Application (2027–2032)
5.1.3 Global Swine Vaccines Sales Market Share by Application (2021–2032)
5.2 Global Swine Vaccines Revenue by Application (2021–2032)
5.2.1 Global Swine Vaccines Revenue by Application (2021–2026)
5.2.2 Global Swine Vaccines Revenue by Application (2027–2032)
5.2.3 Global Swine Vaccines Revenue Market Share by Application (2021–2032)
5.3 Global Swine Vaccines Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Swine Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Merck Swine Vaccines Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Boehringer Ingelheim
6.2.1 Boehringer Ingelheim Company Information
6.2.2 Boehringer Ingelheim Description and Business Overview
6.2.3 Boehringer Ingelheim Swine Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Boehringer Ingelheim Swine Vaccines Product Portfolio
6.2.5 Boehringer Ingelheim Recent Developments/Updates
6.3 Jinyu Bio-Technology
6.3.1 Jinyu Bio-Technology Company Information
6.3.2 Jinyu Bio-Technology Description and Business Overview
6.3.3 Jinyu Bio-Technology Swine Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Jinyu Bio-Technology Swine Vaccines Product Portfolio
6.3.5 Jinyu Bio-Technology Recent Developments/Updates
6.4 CAHIC
6.4.1 CAHIC Company Information
6.4.2 CAHIC Description and Business Overview
6.4.3 CAHIC Swine Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 CAHIC Swine Vaccines Product Portfolio
6.4.5 CAHIC Recent Developments/Updates
6.5 Tecon
6.5.1 Tecon Company Information
6.5.2 Tecon Description and Business Overview
6.5.3 Tecon Swine Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Tecon Swine Vaccines Product Portfolio
6.5.5 Tecon Recent Developments/Updates
6.6 Zoetis
6.6.1 Zoetis Company Information
6.6.2 Zoetis Description and Business Overview
6.6.3 Zoetis Swine Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Zoetis Swine Vaccines Product Portfolio
6.6.5 Zoetis Recent Developments/Updates
6.7 Ceva
6.7.1 Ceva Company Information
6.7.2 Ceva Description and Business Overview
6.7.3 Ceva Swine Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Ceva Swine Vaccines Product Portfolio
6.7.5 Ceva Recent Developments/Updates
6.8 Hile Bio
6.8.1 Hile Bio Company Information
6.8.2 Hile Bio Description and Business Overview
6.8.3 Hile Bio Swine Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Hile Bio Swine Vaccines Product Portfolio
6.8.5 Hile Bio Recent Developments/Updates
6.9 Chopper Biology
6.9.1 Chopper Biology Company Information
6.9.2 Chopper Biology Description and Business Overview
6.9.3 Chopper Biology Swine Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Chopper Biology Swine Vaccines Product Portfolio
6.9.5 Chopper Biology Recent Developments/Updates
6.10 WINSUN
6.10.1 WINSUN Company Information
6.10.2 WINSUN Description and Business Overview
6.10.3 WINSUN Swine Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 WINSUN Swine Vaccines Product Portfolio
6.10.5 WINSUN Recent Developments/Updates
6.11 Hipra
6.11.1 Hipra Company Information
6.11.2 Hipra Description and Business Overview
6.11.3 Hipra Swine Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Hipra Swine Vaccines Product Portfolio
6.11.5 Hipra Recent Developments/Updates
6.12 Ringpu Biology
6.12.1 Ringpu Biology Company Information
6.12.2 Ringpu Biology Description and Business Overview
6.12.3 Ringpu Biology Swine Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Ringpu Biology Swine Vaccines Product Portfolio
6.12.5 Ringpu Biology Recent Developments/Updates
6.13 ChengDu Tecbond
6.13.1 ChengDu Tecbond Company Information
6.13.2 ChengDu Tecbond Description and Business Overview
6.13.3 ChengDu Tecbond Swine Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 ChengDu Tecbond Swine Vaccines Product Portfolio
6.13.5 ChengDu Tecbond Recent Developments/Updates
6.14 DHN
6.14.1 DHN Company Information
6.14.2 DHN Description and Business Overview
6.14.3 DHN Swine Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 DHN Swine Vaccines Product Portfolio
6.14.5 DHN Recent Developments/Updates
6.15 CAVAC
6.15.1 CAVAC Company Information
6.15.2 CAVAC Description and Business Overview
6.15.3 CAVAC Swine Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 CAVAC Swine Vaccines Product Portfolio
6.15.5 CAVAC Recent Developments/Updates
6.16 Virbac
6.16.1 Virbac Company Information
6.16.2 Virbac Description and Business Overview
6.16.3 Virbac Swine Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Virbac Swine Vaccines Product Portfolio
6.16.5 Virbac Recent Developments/Updates
6.17 HVRI
6.17.1 HVRI Company Information
6.17.2 HVRI Description and Business Overview
6.17.3 HVRI Swine Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 HVRI Swine Vaccines Product Portfolio
6.17.5 HVRI Recent Developments/Updates
6.18 Bioveta
6.18.1 Bioveta Company Information
6.18.2 Bioveta Description and Business Overview
6.18.3 Bioveta Swine Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Bioveta Swine Vaccines Product Portfolio
6.18.5 Bioveta Recent Developments/Updates
6.19 Cavet Bio
6.19.1 Cavet Bio Company Information
6.19.2 Cavet Bio Description and Business Overview
6.19.3 Cavet Bio Swine Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 Cavet Bio Swine Vaccines Product Portfolio
6.19.5 Cavet Bio Recent Developments/Updates
6.20 BIGVET Biotech
6.20.1 BIGVET Biotech Company Information
6.20.2 BIGVET Biotech Description and Business Overview
6.20.3 BIGVET Biotech Swine Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.20.4 BIGVET Biotech Swine Vaccines Product Portfolio
6.20.5 BIGVET Biotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Swine Vaccines Industry Chain Analysis
7.2 Swine Vaccines Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Swine Vaccines Production Mode & Process Analysis
7.4 Swine Vaccines Sales and Marketing
7.4.1 Swine Vaccines Sales Channels
7.4.2 Swine Vaccines Distributors
7.5 Swine Vaccines Customer Analysis
8 Swine Vaccines Market Dynamics
8.1 Swine Vaccines Industry Trends
8.2 Swine Vaccines Market Drivers
8.3 Swine Vaccines Market Challenges
8.4 Swine Vaccines Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Swine Vaccines Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Swine Vaccines Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Swine Vaccines Market Competitive Situation by Manufacturers in 2025
Table 4. Global Swine Vaccines Sales (M Doses) of Key Manufacturers (2021–2026)
Table 5. Global Swine Vaccines Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Swine Vaccines Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Swine Vaccines Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Swine Vaccines Average Price (USD/K Doses) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Swine Vaccines, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Swine Vaccines, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Swine Vaccines, Product Types and Applications
Table 12. Global Key Manufacturers of Swine Vaccines, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Swine Vaccines Companies by Tier (Tier 1, Tier 2, Tier 3), based on Swine Vaccines Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Swine Vaccines Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Swine Vaccines Sales by Region (M Doses), 2021–2026
Table 18. Global Swine Vaccines Sales Market Share by Region (2021–2026)
Table 19. Global Swine Vaccines Sales by Region (M Doses), 2027–2032
Table 20. Global Swine Vaccines Sales Market Share by Region (2027–2032)
Table 21. Global Swine Vaccines Revenue by Region (US$ Million), 2021–2026
Table 22. Global Swine Vaccines Revenue Market Share by Region (2021–2026)
Table 23. Global Swine Vaccines Revenue by Region (US$ Million), 2027–2032
Table 24. Global Swine Vaccines Revenue Market Share by Region (2027–2032)
Table 25. North America Swine Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Swine Vaccines Sales by Country (M Doses), 2021–2026
Table 27. North America Swine Vaccines Sales by Country (M Doses), 2027–2032
Table 28. North America Swine Vaccines Revenue by Country (US$ Million), 2021–2026
Table 29. North America Swine Vaccines Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Swine Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Swine Vaccines Sales by Country (M Doses), 2021–2026
Table 32. Europe Swine Vaccines Sales by Country (M Doses), 2027–2032
Table 33. Europe Swine Vaccines Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Swine Vaccines Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Swine Vaccines Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Swine Vaccines Sales by Region (M Doses), 2021–2026
Table 37. Asia Pacific Swine Vaccines Sales by Region (M Doses), 2027–2032
Table 38. Asia Pacific Swine Vaccines Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Swine Vaccines Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Swine Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Swine Vaccines Sales by Country (M Doses), 2021–2026
Table 42. Latin America Swine Vaccines Sales by Country (M Doses), 2027–2032
Table 43. Latin America Swine Vaccines Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Swine Vaccines Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Swine Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Swine Vaccines Sales by Country (M Doses), 2021–2026
Table 47. Middle East and Africa Swine Vaccines Sales by Country (M Doses), 2027–2032
Table 48. Middle East and Africa Swine Vaccines Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Swine Vaccines Revenue by Country (US$ Million), 2027–2032
Table 50. Global Swine Vaccines Sales (M Doses) by Type (2021–2026)
Table 51. Global Swine Vaccines Sales (M Doses) by Type (2027–2032)
Table 52. Global Swine Vaccines Sales Market Share by Type (2021–2026)
Table 53. Global Swine Vaccines Sales Market Share by Type (2027–2032)
Table 54. Global Swine Vaccines Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Swine Vaccines Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Swine Vaccines Revenue Market Share by Type (2021–2026)
Table 57. Global Swine Vaccines Revenue Market Share by Type (2027–2032)
Table 58. Global Swine Vaccines Price (USD/K Doses) by Type (2021–2026)
Table 59. Global Swine Vaccines Price (USD/K Doses) by Type (2027–2032)
Table 60. Global Swine Vaccines Sales (M Doses) by Application (2021–2026)
Table 61. Global Swine Vaccines Sales (M Doses) by Application (2027–2032)
Table 62. Global Swine Vaccines Sales Market Share by Application (2021–2026)
Table 63. Global Swine Vaccines Sales Market Share by Application (2027–2032)
Table 64. Global Swine Vaccines Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Swine Vaccines Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Swine Vaccines Revenue Market Share by Application (2021–2026)
Table 67. Global Swine Vaccines Revenue Market Share by Application (2027–2032)
Table 68. Global Swine Vaccines Price (USD/K Doses) by Application (2021–2026)
Table 69. Global Swine Vaccines Price (USD/K Doses) by Application (2027–2032)
Table 70. Merck Company Information
Table 71. Merck Description and Business Overview
Table 72. Merck Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 73. Merck Swine Vaccines Product
Table 74. Merck Recent Developments/Updates
Table 75. Boehringer Ingelheim Company Information
Table 76. Boehringer Ingelheim Description and Business Overview
Table 77. Boehringer Ingelheim Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 78. Boehringer Ingelheim Swine Vaccines Product
Table 79. Boehringer Ingelheim Recent Developments/Updates
Table 80. Jinyu Bio-Technology Company Information
Table 81. Jinyu Bio-Technology Description and Business Overview
Table 82. Jinyu Bio-Technology Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 83. Jinyu Bio-Technology Swine Vaccines Product
Table 84. Jinyu Bio-Technology Recent Developments/Updates
Table 85. CAHIC Company Information
Table 86. CAHIC Description and Business Overview
Table 87. CAHIC Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 88. CAHIC Swine Vaccines Product
Table 89. CAHIC Recent Developments/Updates
Table 90. Tecon Company Information
Table 91. Tecon Description and Business Overview
Table 92. Tecon Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 93. Tecon Swine Vaccines Product
Table 94. Tecon Recent Developments/Updates
Table 95. Zoetis Company Information
Table 96. Zoetis Description and Business Overview
Table 97. Zoetis Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 98. Zoetis Swine Vaccines Product
Table 99. Zoetis Recent Developments/Updates
Table 100. Ceva Company Information
Table 101. Ceva Description and Business Overview
Table 102. Ceva Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 103. Ceva Swine Vaccines Product
Table 104. Ceva Recent Developments/Updates
Table 105. Hile Bio Company Information
Table 106. Hile Bio Description and Business Overview
Table 107. Hile Bio Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 108. Hile Bio Swine Vaccines Product
Table 109. Hile Bio Recent Developments/Updates
Table 110. Chopper Biology Company Information
Table 111. Chopper Biology Description and Business Overview
Table 112. Chopper Biology Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 113. Chopper Biology Swine Vaccines Product
Table 114. Chopper Biology Recent Developments/Updates
Table 115. WINSUN Company Information
Table 116. WINSUN Description and Business Overview
Table 117. WINSUN Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 118. WINSUN Swine Vaccines Product
Table 119. WINSUN Recent Developments/Updates
Table 120. Hipra Company Information
Table 121. Hipra Description and Business Overview
Table 122. Hipra Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 123. Hipra Swine Vaccines Product
Table 124. Hipra Recent Developments/Updates
Table 125. Ringpu Biology Company Information
Table 126. Ringpu Biology Description and Business Overview
Table 127. Ringpu Biology Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 128. Ringpu Biology Swine Vaccines Product
Table 129. Ringpu Biology Recent Developments/Updates
Table 130. ChengDu Tecbond Company Information
Table 131. ChengDu Tecbond Description and Business Overview
Table 132. ChengDu Tecbond Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 133. ChengDu Tecbond Swine Vaccines Product
Table 134. ChengDu Tecbond Recent Developments/Updates
Table 135. DHN Company Information
Table 136. DHN Description and Business Overview
Table 137. DHN Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 138. DHN Swine Vaccines Product
Table 139. DHN Recent Developments/Updates
Table 140. CAVAC Company Information
Table 141. CAVAC Description and Business Overview
Table 142. CAVAC Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 143. CAVAC Swine Vaccines Product
Table 144. CAVAC Recent Developments/Updates
Table 145. Virbac Company Information
Table 146. Virbac Description and Business Overview
Table 147. Virbac Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 148. Virbac Swine Vaccines Product
Table 149. Virbac Recent Developments/Updates
Table 150. HVRI Company Information
Table 151. HVRI Description and Business Overview
Table 152. HVRI Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 153. HVRI Swine Vaccines Product
Table 154. HVRI Recent Developments/Updates
Table 155. Bioveta Company Information
Table 156. Bioveta Description and Business Overview
Table 157. Bioveta Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 158. Bioveta Swine Vaccines Product
Table 159. Bioveta Recent Developments/Updates
Table 160. Cavet Bio Company Information
Table 161. Cavet Bio Description and Business Overview
Table 162. Cavet Bio Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 163. Cavet Bio Swine Vaccines Product
Table 164. Cavet Bio Recent Developments/Updates
Table 165. BIGVET Biotech Company Information
Table 166. BIGVET Biotech Description and Business Overview
Table 167. BIGVET Biotech Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 168. BIGVET Biotech Swine Vaccines Product
Table 169. BIGVET Biotech Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Swine Vaccines Distributors List
Table 173. Swine Vaccines Customers List
Table 174. Swine Vaccines Market Trends
Table 175. Swine Vaccines Market Drivers
Table 176. Swine Vaccines Market Challenges
Table 177. Swine Vaccines Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
Table 181. Authors List of This Report
List of Figures
Figure 1. Product Picture of Swine Vaccines
Figure 2. Global Swine Vaccines Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Swine Vaccines Market Share by Type: 2025 & 2032
Figure 4. CSF Vaccines Product Picture
Figure 5. FMD Vaccines Product Picture
Figure 6. Porcine Circovirus Vaccines Product Picture
Figure 7. PRRS Vaccines Product Picture
Figure 8. Others Product Picture
Figure 9. Global Swine Vaccines Market Value by Application (US$ Million), 2021–2032
Figure 10. Global Swine Vaccines Market Share by Application: 2025 & 2032
Figure 11. Government Tender
Figure 12. Market Sales
Figure 13. Global Swine Vaccines Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Swine Vaccines Market Size (US$ Million), 2021–2032
Figure 15. Global Swine Vaccines Sales (M Doses), 2021–2032
Figure 16. Global Swine Vaccines Average Price (USD/K Doses), 2021–2032
Figure 17. Swine Vaccines Report Years Considered
Figure 18. Swine Vaccines Sales Share by Manufacturers in 2025
Figure 19. Global Swine Vaccines Revenue Share by Manufacturers in 2025
Figure 20. Top 5 and Top 10 Global Swine Vaccines Players: Market Share by Revenue in Swine Vaccines in 2025
Figure 21. Swine Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 22. Global Swine Vaccines Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 23. North America Swine Vaccines Sales Market Share by Country (2021–2032)
Figure 24. North America Swine Vaccines Revenue Market Share by Country (2021–2032)
Figure 25. U.S. Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Canada Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Europe Swine Vaccines Sales Market Share by Country (2021–2032)
Figure 28. Europe Swine Vaccines Revenue Market Share by Country (2021–2032)
Figure 29. Germany Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. France Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. U.K. Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Italy Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Russia Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Asia Pacific Swine Vaccines Sales Market Share by Region (2021–2032)
Figure 35. Asia Pacific Swine Vaccines Revenue Market Share by Region (2021–2032)
Figure 36. China Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Japan Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. South Korea Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. India Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Australia Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Taiwan Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Indonesia Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Thailand Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Malaysia Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Philippines Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Latin America Swine Vaccines Sales Market Share by Country (2021–2032)
Figure 47. Latin America Swine Vaccines Revenue Market Share by Country (2021–2032)
Figure 48. Mexico Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Brazil Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Argentina Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Middle East and Africa Swine Vaccines Sales Market Share by Country (2021–2032)
Figure 52. Middle East and Africa Swine Vaccines Revenue Market Share by Country (2021–2032)
Figure 53. Turkey Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Saudi Arabia Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. U.A.E Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. Global Sales Market Share of Swine Vaccines by Type (2021–2032)
Figure 57. Global Revenue Market Share of Swine Vaccines by Type (2021–2032)
Figure 58. Global Swine Vaccines Price (USD/K Doses) by Type (2021–2032)
Figure 59. Global Sales Market Share of Swine Vaccines by Application (2021–2032)
Figure 60. Global Revenue Market Share of Swine Vaccines by Application (2021–2032)
Figure 61. Global Swine Vaccines Price (USD/K Doses) by Application (2021–2032)
Figure 62. Swine Vaccines Value Chain
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Table 1. Global Swine Vaccines Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Swine Vaccines Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Swine Vaccines Market Competitive Situation by Manufacturers in 2025
Table 4. Global Swine Vaccines Sales (M Doses) of Key Manufacturers (2021–2026)
Table 5. Global Swine Vaccines Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Swine Vaccines Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Swine Vaccines Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Swine Vaccines Average Price (USD/K Doses) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Swine Vaccines, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Swine Vaccines, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Swine Vaccines, Product Types and Applications
Table 12. Global Key Manufacturers of Swine Vaccines, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Swine Vaccines Companies by Tier (Tier 1, Tier 2, Tier 3), based on Swine Vaccines Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Swine Vaccines Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Swine Vaccines Sales by Region (M Doses), 2021–2026
Table 18. Global Swine Vaccines Sales Market Share by Region (2021–2026)
Table 19. Global Swine Vaccines Sales by Region (M Doses), 2027–2032
Table 20. Global Swine Vaccines Sales Market Share by Region (2027–2032)
Table 21. Global Swine Vaccines Revenue by Region (US$ Million), 2021–2026
Table 22. Global Swine Vaccines Revenue Market Share by Region (2021–2026)
Table 23. Global Swine Vaccines Revenue by Region (US$ Million), 2027–2032
Table 24. Global Swine Vaccines Revenue Market Share by Region (2027–2032)
Table 25. North America Swine Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Swine Vaccines Sales by Country (M Doses), 2021–2026
Table 27. North America Swine Vaccines Sales by Country (M Doses), 2027–2032
Table 28. North America Swine Vaccines Revenue by Country (US$ Million), 2021–2026
Table 29. North America Swine Vaccines Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Swine Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Swine Vaccines Sales by Country (M Doses), 2021–2026
Table 32. Europe Swine Vaccines Sales by Country (M Doses), 2027–2032
Table 33. Europe Swine Vaccines Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Swine Vaccines Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Swine Vaccines Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Swine Vaccines Sales by Region (M Doses), 2021–2026
Table 37. Asia Pacific Swine Vaccines Sales by Region (M Doses), 2027–2032
Table 38. Asia Pacific Swine Vaccines Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Swine Vaccines Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Swine Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Swine Vaccines Sales by Country (M Doses), 2021–2026
Table 42. Latin America Swine Vaccines Sales by Country (M Doses), 2027–2032
Table 43. Latin America Swine Vaccines Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Swine Vaccines Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Swine Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Swine Vaccines Sales by Country (M Doses), 2021–2026
Table 47. Middle East and Africa Swine Vaccines Sales by Country (M Doses), 2027–2032
Table 48. Middle East and Africa Swine Vaccines Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Swine Vaccines Revenue by Country (US$ Million), 2027–2032
Table 50. Global Swine Vaccines Sales (M Doses) by Type (2021–2026)
Table 51. Global Swine Vaccines Sales (M Doses) by Type (2027–2032)
Table 52. Global Swine Vaccines Sales Market Share by Type (2021–2026)
Table 53. Global Swine Vaccines Sales Market Share by Type (2027–2032)
Table 54. Global Swine Vaccines Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Swine Vaccines Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Swine Vaccines Revenue Market Share by Type (2021–2026)
Table 57. Global Swine Vaccines Revenue Market Share by Type (2027–2032)
Table 58. Global Swine Vaccines Price (USD/K Doses) by Type (2021–2026)
Table 59. Global Swine Vaccines Price (USD/K Doses) by Type (2027–2032)
Table 60. Global Swine Vaccines Sales (M Doses) by Application (2021–2026)
Table 61. Global Swine Vaccines Sales (M Doses) by Application (2027–2032)
Table 62. Global Swine Vaccines Sales Market Share by Application (2021–2026)
Table 63. Global Swine Vaccines Sales Market Share by Application (2027–2032)
Table 64. Global Swine Vaccines Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Swine Vaccines Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Swine Vaccines Revenue Market Share by Application (2021–2026)
Table 67. Global Swine Vaccines Revenue Market Share by Application (2027–2032)
Table 68. Global Swine Vaccines Price (USD/K Doses) by Application (2021–2026)
Table 69. Global Swine Vaccines Price (USD/K Doses) by Application (2027–2032)
Table 70. Merck Company Information
Table 71. Merck Description and Business Overview
Table 72. Merck Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 73. Merck Swine Vaccines Product
Table 74. Merck Recent Developments/Updates
Table 75. Boehringer Ingelheim Company Information
Table 76. Boehringer Ingelheim Description and Business Overview
Table 77. Boehringer Ingelheim Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 78. Boehringer Ingelheim Swine Vaccines Product
Table 79. Boehringer Ingelheim Recent Developments/Updates
Table 80. Jinyu Bio-Technology Company Information
Table 81. Jinyu Bio-Technology Description and Business Overview
Table 82. Jinyu Bio-Technology Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 83. Jinyu Bio-Technology Swine Vaccines Product
Table 84. Jinyu Bio-Technology Recent Developments/Updates
Table 85. CAHIC Company Information
Table 86. CAHIC Description and Business Overview
Table 87. CAHIC Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 88. CAHIC Swine Vaccines Product
Table 89. CAHIC Recent Developments/Updates
Table 90. Tecon Company Information
Table 91. Tecon Description and Business Overview
Table 92. Tecon Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 93. Tecon Swine Vaccines Product
Table 94. Tecon Recent Developments/Updates
Table 95. Zoetis Company Information
Table 96. Zoetis Description and Business Overview
Table 97. Zoetis Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 98. Zoetis Swine Vaccines Product
Table 99. Zoetis Recent Developments/Updates
Table 100. Ceva Company Information
Table 101. Ceva Description and Business Overview
Table 102. Ceva Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 103. Ceva Swine Vaccines Product
Table 104. Ceva Recent Developments/Updates
Table 105. Hile Bio Company Information
Table 106. Hile Bio Description and Business Overview
Table 107. Hile Bio Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 108. Hile Bio Swine Vaccines Product
Table 109. Hile Bio Recent Developments/Updates
Table 110. Chopper Biology Company Information
Table 111. Chopper Biology Description and Business Overview
Table 112. Chopper Biology Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 113. Chopper Biology Swine Vaccines Product
Table 114. Chopper Biology Recent Developments/Updates
Table 115. WINSUN Company Information
Table 116. WINSUN Description and Business Overview
Table 117. WINSUN Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 118. WINSUN Swine Vaccines Product
Table 119. WINSUN Recent Developments/Updates
Table 120. Hipra Company Information
Table 121. Hipra Description and Business Overview
Table 122. Hipra Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 123. Hipra Swine Vaccines Product
Table 124. Hipra Recent Developments/Updates
Table 125. Ringpu Biology Company Information
Table 126. Ringpu Biology Description and Business Overview
Table 127. Ringpu Biology Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 128. Ringpu Biology Swine Vaccines Product
Table 129. Ringpu Biology Recent Developments/Updates
Table 130. ChengDu Tecbond Company Information
Table 131. ChengDu Tecbond Description and Business Overview
Table 132. ChengDu Tecbond Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 133. ChengDu Tecbond Swine Vaccines Product
Table 134. ChengDu Tecbond Recent Developments/Updates
Table 135. DHN Company Information
Table 136. DHN Description and Business Overview
Table 137. DHN Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 138. DHN Swine Vaccines Product
Table 139. DHN Recent Developments/Updates
Table 140. CAVAC Company Information
Table 141. CAVAC Description and Business Overview
Table 142. CAVAC Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 143. CAVAC Swine Vaccines Product
Table 144. CAVAC Recent Developments/Updates
Table 145. Virbac Company Information
Table 146. Virbac Description and Business Overview
Table 147. Virbac Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 148. Virbac Swine Vaccines Product
Table 149. Virbac Recent Developments/Updates
Table 150. HVRI Company Information
Table 151. HVRI Description and Business Overview
Table 152. HVRI Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 153. HVRI Swine Vaccines Product
Table 154. HVRI Recent Developments/Updates
Table 155. Bioveta Company Information
Table 156. Bioveta Description and Business Overview
Table 157. Bioveta Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 158. Bioveta Swine Vaccines Product
Table 159. Bioveta Recent Developments/Updates
Table 160. Cavet Bio Company Information
Table 161. Cavet Bio Description and Business Overview
Table 162. Cavet Bio Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 163. Cavet Bio Swine Vaccines Product
Table 164. Cavet Bio Recent Developments/Updates
Table 165. BIGVET Biotech Company Information
Table 166. BIGVET Biotech Description and Business Overview
Table 167. BIGVET Biotech Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 168. BIGVET Biotech Swine Vaccines Product
Table 169. BIGVET Biotech Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Swine Vaccines Distributors List
Table 173. Swine Vaccines Customers List
Table 174. Swine Vaccines Market Trends
Table 175. Swine Vaccines Market Drivers
Table 176. Swine Vaccines Market Challenges
Table 177. Swine Vaccines Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
Table 181. Authors List of This Report
List of Figures
Figure 1. Product Picture of Swine Vaccines
Figure 2. Global Swine Vaccines Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Swine Vaccines Market Share by Type: 2025 & 2032
Figure 4. CSF Vaccines Product Picture
Figure 5. FMD Vaccines Product Picture
Figure 6. Porcine Circovirus Vaccines Product Picture
Figure 7. PRRS Vaccines Product Picture
Figure 8. Others Product Picture
Figure 9. Global Swine Vaccines Market Value by Application (US$ Million), 2021–2032
Figure 10. Global Swine Vaccines Market Share by Application: 2025 & 2032
Figure 11. Government Tender
Figure 12. Market Sales
Figure 13. Global Swine Vaccines Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Swine Vaccines Market Size (US$ Million), 2021–2032
Figure 15. Global Swine Vaccines Sales (M Doses), 2021–2032
Figure 16. Global Swine Vaccines Average Price (USD/K Doses), 2021–2032
Figure 17. Swine Vaccines Report Years Considered
Figure 18. Swine Vaccines Sales Share by Manufacturers in 2025
Figure 19. Global Swine Vaccines Revenue Share by Manufacturers in 2025
Figure 20. Top 5 and Top 10 Global Swine Vaccines Players: Market Share by Revenue in Swine Vaccines in 2025
Figure 21. Swine Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 22. Global Swine Vaccines Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 23. North America Swine Vaccines Sales Market Share by Country (2021–2032)
Figure 24. North America Swine Vaccines Revenue Market Share by Country (2021–2032)
Figure 25. U.S. Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Canada Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Europe Swine Vaccines Sales Market Share by Country (2021–2032)
Figure 28. Europe Swine Vaccines Revenue Market Share by Country (2021–2032)
Figure 29. Germany Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. France Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. U.K. Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Italy Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Russia Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Asia Pacific Swine Vaccines Sales Market Share by Region (2021–2032)
Figure 35. Asia Pacific Swine Vaccines Revenue Market Share by Region (2021–2032)
Figure 36. China Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Japan Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. South Korea Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. India Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Australia Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Taiwan Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Indonesia Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Thailand Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Malaysia Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Philippines Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Latin America Swine Vaccines Sales Market Share by Country (2021–2032)
Figure 47. Latin America Swine Vaccines Revenue Market Share by Country (2021–2032)
Figure 48. Mexico Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Brazil Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Argentina Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Middle East and Africa Swine Vaccines Sales Market Share by Country (2021–2032)
Figure 52. Middle East and Africa Swine Vaccines Revenue Market Share by Country (2021–2032)
Figure 53. Turkey Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Saudi Arabia Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. U.A.E Swine Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. Global Sales Market Share of Swine Vaccines by Type (2021–2032)
Figure 57. Global Revenue Market Share of Swine Vaccines by Type (2021–2032)
Figure 58. Global Swine Vaccines Price (USD/K Doses) by Type (2021–2032)
Figure 59. Global Sales Market Share of Swine Vaccines by Application (2021–2032)
Figure 60. Global Revenue Market Share of Swine Vaccines by Application (2021–2032)
Figure 61. Global Swine Vaccines Price (USD/K Doses) by Application (2021–2032)
Figure 62. Swine Vaccines Value Chain
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Smart Grid Digital Substation Market Research Report 2026
Mar 17, 26
Global Photovoltaic Molded Case Circuit Breaker Market Research Report 2026
Mar 17, 26
Global Roll-Roll Automobile Business Market Research Report 2026
Mar 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232